William Calhoun

View Scopus Profile

Emailwjcalhouutmbedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Allergy/Immunology, Fellowship, University of Wisconsin-Madison

… → 1992

Pulmonary, Fellowship, University of Vermont, Burlington

… → 1985

Medicine, Residency, Pennsylvania State University, Hershey

… → 1982

Medicine, MD, Pennsylvania State University, Hershey

… → 1979

Chemistry, BS, University of Delaware

… → 1975

Research interests

Asthma

Research Strategic Pillar Keywords

Infectious/ Immunological Health
Specialized Health

Fingerprint

Dive into the research topics where William Calhoun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

5 Active
38 Completed

Establishing the Prevalence of Allergic Bronchopulmonary Aspergillosis
Calhoun, W.
Pulmatrix, Inc.
12/21/20 → 12/1/22
Project: Other project
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammatio
Calhoun, W.
11/7/19 → 11/6/22
Project: Other project
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammatio
Calhoun, W.
11/7/19 → 11/6/22
Project: Other project
Study D3250C00059: A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK)
Calhoun, W.
8/19/19 → 8/18/23
Project: Other project
Post-authorisation Safety (PAS) Observational Cohort Study to Quantify the Incidence and Comparative Safety of Selected Cardiovascular and Cerebrovascular Events in COPD Patients Using Inhaled UMEC/VI Combination or Inhaled UMEC versus Tiotropium (Study
Calhoun, W.
12/7/16 → 12/6/22
Project: Other project

146 Article
26 Review article
9 Chapter
7 Editorial
More

Optical biosensing of markers of mucosal inflammation
Covarrubias-Zambrano, O., Motamedi, M., Ameredes, B. T., Tian, B., Calhoun, W. J., Zhao, Y., Brasier, A. R., Kalubowilage, M., Malalasekera, A. P., Yapa, A. S., Wang, H., Culbertson, C. T., Troyer, D. L. & Bossmann, S. H., Feb 2022, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 40, 102476.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
The new era of add-on asthma treatments: where do we stand?
Calhoun, W. J. & Chupp, G. L., Dec 2022, In: Allergy, Asthma and Clinical Immunology. 18, 1, 42.
Research output: Contribution to journal › Review article › peer-review

Open Access
A comprehensive analysis of the stability of blood eosinophil levels
Chipps, B. E., Jarjour, N., Calhoun, W. J., Iqbal, A., Haselkorn, T., Yang, M., Brumm, J., Corren, J., Holweg, C. T. J. & Bafadhel, M., Dec 2021, In: Annals of the American Thoracic Society. 18, 12, p. 1978-1987 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
Benefits of airway androgen receptor expression in human asthma
Zein, J. G., McManus, J. M., Sharifi, N., Erzurum, S. C., Marozkina, N., Lahm, T., Giddings, O., Davis, M. D., DeBoer, M. D., Comhair, S. A., Bazeley, P., Jo Kim, H., Busse, W., Calhoun, W., Castro, M., Chung, K. F., Fahy, J. V., Israel, E., Jarjour, N. N., Levy, B. D., & 9 othersMauger, D. T., Moore, W. C., Ortega, V. E., Peters, M., Bleecker, E. R., Meyers, D. A., Zhao, Y., Wenzel, S. E. & Gaston, B., Aug 1 2021, In: American Journal of Respiratory and Critical Care Medicine. 204, 3, p. 285-293 9 p.
Research output: Contribution to journal › Article › peer-review
9 Scopus citations
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
ANDHI study investigators, Mar 2021, In: The Lancet Respiratory Medicine. 9, 3, p. 260-274 15 p.
Research output: Contribution to journal › Article › peer-review
31 Scopus citations

William Calhoun, MD

Personal profile

Education/Academic qualification

Research interests

Research Strategic Pillar Keywords

Fingerprint

Network

Dive into details

Establishing the Prevalence of Allergic Bronchopulmonary Aspergillosis

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammatio

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 inflammatio

Study D3250C00059: A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK)

Post-authorisation Safety (PAS) Observational Cohort Study to Quantify the Incidence and Comparative Safety of Selected Cardiovascular and Cerebrovascular Events in COPD Patients Using Inhaled UMEC/VI Combination or Inhaled UMEC versus Tiotropium (Study

Optical biosensing of markers of mucosal inflammation

The new era of add-on asthma treatments: where do we stand?

A comprehensive analysis of the stability of blood eosinophil levels

Benefits of airway androgen receptor expression in human asthma

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

William Calhoun, MD

Personal profile

Education/Academic qualification

Research interests

Research Strategic Pillar Keywords

Fingerprint

Network

Projects

Research output